Evidence map›Paper›PMID 33064753›Full record

ArticlePloS one2020

COVID-19 observations and accompanying dataset of non-pharmaceutical interventions across U.S. universities, March 2020.

Kevin E Cevasco, Hayley M North, Sheryne A Zeitoun, Rachel N Wofford, Graham A Matulis, Abigail F Gregory, Maha H Hassan, Aya D Abdo, David Farris, Amira A Roess and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Kevin E CevascoDepartment of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, Virginia, United States of America.
Hayley M NorthDepartment of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, Virginia, United States of America.
Sheryne A ZeitounDepartment of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, Virginia, United States of America.
Rachel N WoffordDepartment of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, Virginia, United States of America.
Graham A MatulisDepartment of Biology, College of Science, George Mason University, Fairfax, Virginia, United States of America.
Abigail F GregoryDepartment of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, Virginia, United States of America.
Maha H HassanDepartment of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, Virginia, United States of America.
Aya D AbdoDepartment of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, Virginia, United States of America.
David FarrisEnvironmental Health and Safety Office, George Mason University, Fairfax, Virginia, United States of America.ORCID 0000-0002-4412-3518
Amira A RoessDepartment of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, Virginia, United States of America.
Michael E von FrickenDepartment of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, Virginia, United States of America.ORCID 0000-0003-2938-4549
George Mason University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Centers for Disease Control and Prevention (CDC) publishes COVID-19 non-pharmaceutical intervention (NPI) guidance for specific institutional audiences to limit community spread. Audiences include: business, clinical, public health, education, community, and state/local government. The swift, severe, and global nature of COVID-19 offers an opportunity to systematically obtain a national view of how larger institutions of higher education adopted NPI guidance at the onset of the pandemic.

methodAn original database of COVID-19-related university NPI policy changes was compiled. Survey team members manually combed university websites and official statements capturing implementation decisions and dates for five NPI variables from 575 U.S. universities, across 50 states and the District of Columbia, during March of 2020. The universities included in this study were selected from the Department of Education Integrated Postsecondary Education Data System (IPEDS), which provides a set of university explanatory variables. Using IPEDS as the basis for the organizational data allows consistent mapping to event-time and institutional characteristic variables including public health announcements, geospatial, census, and political affiliation.

resultsThe dataset enables event-time analysis and offers a variety of variables to support institutional level study and identification of underlying biases like educational attainment. A descriptive analysis of the dataset reveals that there was substantial heterogeneity in the decisions that were made and the timing of these decisions as they temporally related to key state, national, and global emergency announcements. The WHO pandemic declaration coincided with the largest number of university decisions to implement NPIs.

conclusionThis study provides descriptive observations and produced an original dataset that will be useful for future research focused on drivers and trends of COVID-19 NPIs for U.S. Universities. This preliminary analysis suggests COVID-19 university decisions appeared to be made largely at the university level, leading to major variations in the nature and timing of the responses both between and within states, which requires further study.

Indexed as

BetacoronavirusUniversitiesCenters for Disease Control and Prevention, U.S.Coronavirus InfectionsCOVID-19Decision MakingEducation, DistanceHumansInfection ControlPandemicsPneumonia, ViralPublic HealthSARS-CoV-2StudentsSurveys and QuestionnairesTravel

Identifiers

PMID33064753
PMCPMC7567344
OpenAlexW3093459192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.